The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COM | 901384107 | 25,474,765 | 2,497,526 | SH | SOLE | 2,497,526 | 0 | 0 | ||
Aadi Bioscience, Inc. | COM | 00032Q104 | 7,167,079 | 989,928 | SH | SOLE | 989,928 | 0 | 0 | ||
AbCellera Biologics Inc. | COM | 00288U106 | 78,794,357 | 10,450,180 | SH | SOLE | 10,450,180 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 789,282,307 | 41,938,486 | SH | SOLE | 41,938,486 | 0 | 0 | ||
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 2,481,233 | 2,591,366 | SH | SOLE | 2,591,366 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 10,715,656 | 9,830,877 | SH | SOLE | 9,830,877 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 988,931 | 3,410,106 | SH | SOLE | 3,410,106 | 0 | 0 | ||
Aerovate Therapeutics, Inc. | COM | 008064107 | 39,603,371 | 1,963,479 | SH | SOLE | 1,963,479 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 4,918,596 | 6,596,830 | SH | SOLE | 6,596,830 | 0 | 0 | ||
Akero Therapeutics, Inc. | COM | 00973Y108 | 90,614,142 | 2,368,378 | SH | SOLE | 2,368,378 | 0 | 0 | ||
Alector, Inc. | COM | 014442107 | 5,972,428 | 964,851 | SH | SOLE | 964,851 | 0 | 0 | ||
Aligos Therapeutics, Inc. | COM | 01626L105 | 1,814,774 | 2,076,400 | SH | SOLE | 2,076,400 | 0 | 0 | ||
Allogene Therapeutics, Inc. | COM | 019770106 | 7,789,891 | 1,576,901 | SH | SOLE | 1,576,901 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 16,884,106 | 775,924 | SH | SOLE | 775,924 | 0 | 0 | ||
Aravive, Inc. | COM | 03890D108 | 6,522,448 | 3,261,224 | SH | SOLE | 3,261,224 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 104,381,640 | 280,159 | SH | SOLE | 280,159 | 0 | 0 | ||
ARS Pharmaceuticals, Inc. | COM | 82835W108 | 13,061,996 | 2,006,451 | SH | SOLE | 2,006,451 | 0 | 0 | ||
Atara Biotherapeutics, Inc. | COM | 046513107 | 2,158,139 | 744,186 | SH | SOLE | 744,186 | 0 | 0 | ||
Athira Pharma, Inc. | COM | 04746L104 | 5,875,888 | 2,350,355 | SH | SOLE | 2,350,355 | 0 | 0 | ||
Atreca, Inc. | CL A COM | 04965G109 | 4,027,346 | 3,532,760 | SH | SOLE | 3,532,760 | 0 | 0 | ||
Avidity Biosciences, Inc. | COM | 05370A108 | 15,412,183 | 1,004,051 | SH | SOLE | 1,004,051 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 2,514,997,370 | 11,668,897 | SH | SOLE | 11,668,897 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 82,211 | 249,123 | SH | SOLE | 249,123 | 0 | 0 | ||
Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 17,947,924 | 843,814 | SH | SOLE | 843,814 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 106,008,222 | 12,710,818 | SH | SOLE | 12,710,818 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 370,508,516 | 3,810,248 | SH | SOLE | 3,810,248 | 0 | 0 | ||
Biomea Fusion, Inc. | COM | 09077A106 | 65,398,508 | 2,108,949 | SH | SOLE | 2,108,949 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 7,949,094 | 2,499,715 | SH | SOLE | 2,499,715 | 0 | 0 | ||
Blueprint Medicines Corporation | COM | 09627Y109 | 15,011,588 | 333,665 | SH | SOLE | 333,665 | 0 | 0 | ||
Cabaletta Bio, Inc. | COM | 12674W109 | 11,114,880 | 1,344,000 | SH | SOLE | 1,344,000 | 0 | 0 | ||
Century Therapeutics, Inc. | COM | 15673T100 | 3,988,210 | 1,149,340 | SH | SOLE | 1,149,340 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 47,720,647 | 16,067,558 | SH | SOLE | 16,067,558 | 0 | 0 | ||
Chinook Therapeutics, Inc. | COM | 16961L106 | 33,687,926 | 1,455,202 | SH | SOLE | 1,455,202 | 0 | 0 | ||
Compass Therapeutics, Inc. | COM | 20454B104 | 5,093,450 | 1,557,630 | SH | SOLE | 1,557,630 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 24,698,106 | 14,614,264 | SH | SOLE | 14,614,264 | 0 | 0 | ||
Denali Therapeutics Inc. | COM | 24823R105 | 25,084,524 | 1,088,738 | SH | SOLE | 1,088,738 | 0 | 0 | ||
Design Therapeutics, Inc. | COM | 25056L103 | 3,617,121 | 626,884 | SH | SOLE | 626,884 | 0 | 0 | ||
DICE Therapeutics, Inc. | COM | 23345J104 | 29,675,269 | 1,035,786 | SH | SOLE | 1,035,786 | 0 | 0 | ||
Edgewise Therapeutics, Inc. | COM | 28036F105 | 3,335,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
Entrada Therapeutics, Inc. | COM | 29384C108 | 70,554,376 | 4,865,819 | SH | SOLE | 4,865,819 | 0 | 0 | ||
Fate Therapeutics, Inc. | COM | 31189P102 | 9,528,787 | 1,671,717 | SH | SOLE | 1,671,717 | 0 | 0 | ||
FibroGen, Inc. | COM | 31572Q808 | 49,213,585 | 2,637,384 | SH | SOLE | 2,637,384 | 0 | 0 | ||
Foghorn Therapeutics Inc. | COM | 344174107 | 279,167 | 45,027 | SH | SOLE | 45,027 | 0 | 0 | ||
Genetron Holdings Limited | ADS | 37186H100 | 478,071 | 455,306 | SH | SOLE | 455,306 | 0 | 0 | ||
Geron Corporation | COM | 374163103 | 6,642,856 | 3,061,224 | SH | SOLE | 3,061,224 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 12,278,834 | 8,131,678 | SH | SOLE | 8,131,678 | 0 | 0 | ||
HOOKIPA Pharma Inc. | COM | 43906K100 | 2,557,994 | 3,475,535 | SH | SOLE | 3,475,535 | 0 | 0 | ||
IDEAYA Biosciences, Inc. | COM | 45166A102 | 11,433,918 | 832,769 | SH | SOLE | 832,769 | 0 | 0 | ||
IGM Biosciences, Inc. | COM | 449585108 | 43,372,453 | 3,156,656 | SH | SOLE | 3,156,656 | 0 | 0 | ||
Immatics N.V. | SHS | N44445109 | 35,790,859 | 5,187,081 | SH | SOLE | 5,187,081 | 0 | 0 | ||
Immunocore Holdings plc | ADS | 45258D105 | 124,624,941 | 2,520,731 | SH | SOLE | 2,520,731 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,614,396,158 | 36,175,400 | SH | SOLE | 36,175,400 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 5,848,150 | 343,000 | SH | SOLE | 343,000 | 0 | 0 | ||
Instil Bio, Inc. | COM | 45783C101 | 3,484,920 | 5,273,789 | SH | SOLE | 5,273,789 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 11,989,490 | 8,881,104 | SH | SOLE | 8,881,104 | 0 | 0 | ||
iTeos Therapeutics, Inc. | COM | 46565G104 | 2,046,209 | 150,346 | SH | SOLE | 150,346 | 0 | 0 | ||
Kala Pharmaceuticals, Inc. | COM | 483119202 | 1,156,036 | 76,813 | SH | SOLE | 76,813 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 30,123,449 | 2,799,577 | SH | SOLE | 2,799,577 | 0 | 0 | ||
Kodiak Sciences Inc. | COM | 50015M109 | 107,325,038 | 17,310,490 | SH | SOLE | 17,310,490 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 24,235,443 | 302,716 | SH | SOLE | 302,716 | 0 | 0 | ||
Kymera Therapeutics, Inc. | COM | 501575104 | 85,329,215 | 2,879,825 | SH | SOLE | 2,879,825 | 0 | 0 | ||
Leap Therapeutics, Inc. | COM | 52187K101 | 2,524,694 | 7,425,570 | SH | SOLE | 7,425,570 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 6,399,791 | 892,579 | SH | SOLE | 892,579 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 374,319,075 | 1,545,113 | SH | SOLE | 1,545,113 | 0 | 0 | ||
Mersana Therapeutics, Inc. | COM | 59045L106 | 7,751,933 | 1,886,115 | SH | SOLE | 1,886,115 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 52,415,769 | 1,409,784 | SH | SOLE | 1,409,784 | 0 | 0 | ||
Monte Rosa Therapeutics, Inc. | COM | 61225M102 | 2,921,990 | 375,095 | SH | SOLE | 375,095 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 5,552,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 2,675,218 | 3,821,740 | SH | SOLE | 3,821,740 | 0 | 0 | ||
Nkarta, Inc. | COM | 65487U108 | 1,420,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Nurix Therapeutics, Inc. | COM | 67080M103 | 34,473,270 | 3,882,125 | SH | SOLE | 3,882,125 | 0 | 0 | ||
Opthea Limited | SPONSORED ADS | 68386J208 | 10,630,994 | 2,691,391 | SH | SOLE | 2,691,391 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 13,059,716 | 1,127,782 | SH | SOLE | 1,127,782 | 0 | 0 | ||
PMV Pharmaceuticals, Inc. | COM | 69353Y103 | 1,536,054 | 322,024 | SH | SOLE | 322,024 | 0 | 0 | ||
POINT Biopharma Global Inc. | COM | 730541109 | 8,499,379 | 1,169,103 | SH | SOLE | 1,169,103 | 0 | 0 | ||
Praxis Precision Medicines, Inc. | COM | 74006W108 | 1,520,851 | 1,879,915 | SH | SOLE | 1,879,915 | 0 | 0 | ||
Prelude Therapeutics Inc. | COM | 74065P101 | 57,705,797 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
Prime Medicine, Inc. | COM | 74168J101 | 12,650,132 | 1,028,466 | SH | SOLE | 1,028,466 | 0 | 0 | ||
Protara Therapeutics, Inc. | COM STK | 74365U107 | 624,970 | 199,671 | SH | SOLE | 199,671 | 0 | 0 | ||
Relay Therapeutics, Inc. | COM | 75943R102 | 4,677,480 | 284,000 | SH | SOLE | 284,000 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 80,852,425 | 4,578,280 | SH | SOLE | 4,578,280 | 0 | 0 | ||
Revolution Medicines, Inc. | COM | 76155X100 | 58,297,738 | 2,691,493 | SH | SOLE | 2,691,493 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 115,929,083 | 6,498,267 | SH | SOLE | 6,498,267 | 0 | 0 | ||
Roivant Sciences Ltd. | SHS | G76279101 | 35,257,433 | 4,777,430 | SH | SOLE | 4,777,430 | 0 | 0 | ||
Sana Biotechnology, Inc. | SHS | 799566104 | 6,540,000 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
Seagen Inc. | COM | 81181C104 | 9,498,630,809 | 46,913,769 | SH | SOLE | 46,913,769 | 0 | 0 | ||
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 6,851,870 | 1,789,000 | SH | SOLE | 1,789,000 | 0 | 0 | ||
SpringWorks Therapeutics, Inc. | COM | 85205L107 | 70,875,141 | 2,753,502 | SH | SOLE | 2,753,502 | 0 | 0 | ||
Stoke Therapeutics, Inc. | COM | 86150R107 | 17,621,415 | 2,115,416 | SH | SOLE | 2,115,416 | 0 | 0 | ||
Summit Therapeutics Inc. | COM | 86627T108 | 11,033,234 | 6,304,705 | SH | SOLE | 6,304,705 | 0 | 0 | ||
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 83,333 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
Talis Biomedical Corporation | COM | 87424L108 | 3,736,169 | 7,624,835 | SH | SOLE | 7,624,835 | 0 | 0 | ||
Tango Therapeutics, Inc. | COM | 87583X109 | 2,962,500 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
TCR2 Therapeutics Inc. | COM | 87808K106 | 1,129,596 | 753,064 | SH | SOLE | 753,064 | 0 | 0 | ||
TScan Therapeutics, Inc. | COM | 89854M101 | 5,848,063 | 2,784,792 | SH | SOLE | 2,784,792 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 18,886,057 | 470,974 | SH | SOLE | 470,974 | 0 | 0 | ||
Vaxcyte, Inc. | COM | 92243G108 | 1,832,210 | 48,885 | SH | SOLE | 48,885 | 0 | 0 | ||
Vera Therapeutics, Inc. | CL A | 92337R101 | 2,586,664 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
Verastem, Inc. | COM | 92337C104 | 10,596,505 | 25,521,447 | SH | SOLE | 25,521,447 | 0 | 0 | ||
Veru Inc. | COM | 92536C103 | 1,867,112 | 1,609,579 | SH | SOLE | 1,609,579 | 0 | 0 | ||
Verve Therapeutics, Inc. | COM | 92539P101 | 20,426,363 | 1,416,530 | SH | SOLE | 1,416,530 | 0 | 0 | ||
Vincerx Pharma, Inc. | COM | 92731L106 | 251,034 | 241,379 | SH | SOLE | 241,379 | 0 | 0 | ||
Vor Biopharma Inc. | COM | 929033108 | 3,410,102 | 633,848 | SH | SOLE | 633,848 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 3,434,012 | 123,127 | SH | SOLE | 123,127 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 26,901,160 | 751,639 | SH | SOLE | 751,639 | 0 | 0 |